Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06297603
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-03-01
Brief Title:
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment With Inadequate Glycemic Control on Basal Insulin With or Without Metformin andor SGLT2 Inhibitor TRANSCEND-T2D-3
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company